Electronic cigarettes and the lung proteome

American Journal of Respiratory and Critical Care Medicine

Volumn 198, Issue 10, 2018, Pages 1350-1351

  Shields, Peter G ^a,b   Song, Min Ae ^a,c   Freudenheim, Jo L ^d   Brasky, Theodore M ^a,b   Mathe, Ewy ^a,b   McElroy, Joseph P ^a,b   Hummon, Amanda B ^c   Wewers, Mark D ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEOME;

DEVICE SAFETY; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SMOKING; ELECTRONIC CIGARETTE; LUNG; SMOKING CESSATION; TOBACCO;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; LUNG; PROTEOME; SMOKING CESSATION; TOBACCO PRODUCTS;

EID: 85056627474     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201806-1151LE     Document Type: Letter

References (5)

1. Ghosh A, Coakley RC, Mascenik T, Rowell TR, Davis ES, Rogers K, et al. Chronic e-cigarette exposure alters the human bronchial epithelial proteome. Am J Respir Crit Care Med 2018;198: 67-76.
2. Green LW, Fielding JE, Brownson RC. The debate about electronic cigarettes: harm minimization or the precautionary principle. Annu Rev Public Health 2018;39:189-191.
3. Russell A, Wainwright M, Tilson M. Means and ENDS: e-cigarettes, the Framework Convention on Tobacco Control, and global health diplomacy in action. Glob Public Health 2018;13: 83-98.
4. Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 2006;8:600-622.
5. Shields PG, Berman M, Brasky TM, Freudenheim JL, Mathe E, McElroy JP, et al. A review of pulmonary toxicity of electronic cigarettes in the context of smoking: a focus on inflammation. Cancer Epidemiol Biomarkers Prev 2017;26:1175-1191.